3/14/2013

A new coronavirus that has infected at least 15 people and killed nine in the past year adheres to the DPP4 cell-surface protein, but diabetes drugs that block the protein aren't effective in stopping the virus, and existing antibodies that block the virus also kill somatic cells, according to new research. It is possible the drugs tested on the virus do not block the portion of the protein where the pathogen adheres, so future research will look more deeply into how the virus attaches. Scientists are also testing a potential vaccine, but it would not be available to humans anytime soon.

Related Summaries